Carmen Gherasim

Carmen Gherasim

Auto-generated profile, based on publicly available information

Carmen Gherasim

Department of Pathology, University of Michigan , Ann Arbor, MI

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
HMHannah E. Maier
Hannah E. Maier
TKTheresa Kowalski-Dobson
Theresa Kowalski-Dobson
AEAshley Eckard
Ashley Eckard
CGCarmen Gherasim
Carmen Gherasim
DMDavid Manthei
David Manthei
AGAubree Gordon
Aubree Gordon
The impact of vaccination prior to infection on postacute sequelae of coronavirus disease 2019 (COVID-19, PASC), also known as long COVID, remains unclear. Here we assess the protective effect of vaccination on long COVID in a community-based setting. The Immunity Associated with SARS-CoV-2 (IASO) study is an ongoing prospective cohort of working adults that began in October 2020. Participants are actively followed for severe acute respiratory syndrome coronavirus 2 infection. We compared the prevalence of symptoms and symptom severity in vaccinated compared to unvaccinated cases. Our primary definition of long COVID was the presence of symptoms at 90 days postinfection; 30 days postinfection was also examined. Overall, by 90 days postinfection, 13% of cases had long COVID, with 27% of unvaccinated cases and 8% of vaccinated cases reporting long COVID (relative risk [RR], 0.31 [95% confidence interval {CI}, .22–.42]). Vaccination was also associated with significantly lower average severity scores at all timepoints (eg, relative severity at 90 days postinfection: −2.70 [95% CI, −1.68 to −3.73]). In the pre-Omicron era, 28% of unvaccinated cases and 18% of vaccinated cases reported long COVID (P = .07), and vaccinated cases reported less severe symptoms including less difficulty breathing (P = .01; 90-day RR, 0.07). Vaccinated cases had lower prevalence of long COVID and reduced symptom severity.

26 July 2024 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
CSChristine L H Snozek
Christine L H Snozek
CYClaire I Yee
Claire I Yee
JBJanetta Bryksin
Janetta Bryksin
RDRejwi Dahal
Rejwi Dahal
BGBenjamin Gerson
Benjamin Gerson
YYYifei K Yang
Yifei K Yang
Objectives: Urine drug testing (UDT) is a critical tool used in medical, forensic, and occupational settings, but interpreting results can be challenging. We performed a study to assess the ability of health care professionals to interpret UDT results accurately. Methods: In total, 911 clinical and laboratory professionals in the United States and Canada responded to a survey with questions gauging expertise in UDT interpretation. Responses were analyzed to identify knowledge gaps. Results: Toxicologists and laboratory PhD scientists performed well, with means of 4.82 and 4.63 questions answered correctly (out of 6 possible), respectively. Physicians specializing in pathology, emergency medicine, primary care, and internal medicine, however, displayed concerning knowledge gaps, as did laboratorians with nondoctoral degrees. Experience and training correlated with interpretation accuracy. Identification of simulated compliance as well as understanding opioid exposure, metabolism, and immunoassay cross-reactivity were among the most clinically significant knowledge gaps. More than 30% of survey respondents indicated that they would seek UDT information from the internet or peers rather than clinical or laboratory experts. Conclusions: The study highlighted the need for targeted education and better collaboration between clinical and laboratory experts and other health care professionals to ensure that when physicians order UDT, they can accurately interpret results and reduce harm.

27 March 2025 in European Journal of Endocrinology
Verified
Journal Article
Closed access
TWTaweesak Wannachalee
Taweesak Wannachalee
PVPeeradon Vibhatavata
Peeradon Vibhatavata
SKSonja Konzen
Sonja Konzen
CLChaelin Lee
Chaelin Lee
CGCarmen Gherasim
Carmen Gherasim
ATAdina F Turcu
Adina F Turcu
Objective: Adrenal vein sampling (AVS) is the standard-of-care for primary aldosteronism (PA) subtyping. Paradoxical bilateral aldosterone suppression (BAS), defined by lower aldosterone/cortisol ratio in both adrenal veins compared to peripheral circulation, has been reported in AVS studies, but the underlying causes remain poorly understood. We aimed to assess the prevalence of BAS in AVS without and with cosyntropin stimulation based on clinical immunoassays, and to probe the BAS results using liquid chromatography mass spectrometry (LC-MS/MS). Methods: We retrospectively assessed the BAS prevalence among patients with confirmed PA who underwent AVS in a referral center between 2015 and 2023. Simultaneous AVS was performed both before and after cosyntropin stimulation. LC-MS/MS quantitation of cortisol and aldosterone was performed in patients with serum available. Results: Of 402 patients, BAS was observed in 102 (25%): Pre-cosyntropin in 31, post-cosyntropin in 48 (including 10 who did not meet successful catheterization criteria in baseline samples), and both pre- and post- cosyntropin in 23. Paradoxically, AVS indicated lateralized PA in 36% and 43% of patients with BAS based on pre- and post-cosyntropin data, respectively. Using LC-MS/MS, BAS was not present in 42/53 (79%) patients with serum available. Compared to LC-MS/MS, immunoassays overestimated cortisol across the analytical range. In contrast, for aldosterone, immunoassays overestimated low concentrations, but underestimated high concentrations, such as those measured in adrenal veins. Conclusions: Apparent BAS derives primarily from artifacts in clinical immunoassays. These data caution against assuming that aldosterone suppression indicates contralateral aldosterone lateralization in cases with partial adrenal vein catheterization failure.

19 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
QWQian Wang
Qian Wang
IMIan A Mellis
Ian A Mellis
YGYicheng Guo
Yicheng Guo
CGCarmen Gherasim
Carmen Gherasim
RVRiccardo Valdez
Riccardo Valdez
DHDavid Ho
David Ho
SARS-CoV-2-neutralizing antibodies were substantially expanded one month after a shot of XBB.1.5 monovalent mRNA vaccine (XBB.1.5 MV) booster, but the durability of this response remained unknown. Here, we addressed this question by performing neutralization assays on four viral variants (D614G, BA.5, XBB.1.5, and JN.1) using sera from 39 adult participants obtained at ~1 month and ~3 months post an XBB.1.5 MV booster. Our findings indicate that the resultant neutralizing antibody titers were robust and generally maintained at stable levels for the study period, similar to those following XBB infection. Importantly, this durability of neutralizing antibody titers contrasts with the decline observed after a booster of the original monovalent or BA.5 bivalent mRNA vaccine. Our results are in line with the recent national data from the Centers for Disease Control and Prevention, showing the efficacy against symptomatic SARS-CoV-2 infection is sustained for up to 4 months after an XBB.1.5 MV booster.

4 September 2025 in The Journal of Applied Laboratory Medicine
Verified
Journal Article
Closed access
BTBenjamin Telford
Benjamin Telford
NFNada Fanous
Nada Fanous
CGCarmen Gherasim
Carmen Gherasim
DMDavid M Manthei
David M Manthei

7 January 2026 in The Journal of Applied Laboratory Medicine
Verified
Journal Article
Open access
NTNga Yeung Tang
Nga Yeung Tang
CGCarmen Gherasim
Carmen Gherasim
LSLee Schroeder
Lee Schroeder
HLHsuan-Chieh Liao
Hsuan-Chieh Liao
QSQian Sun
Qian Sun
Background: Bicarbonate concentration is widely used to assess acid-base disorders in patients, and the concentration can be directly measured or calculated. When discrepant results between measured bicarbonate (mHCO3−) and calculated bicarbonate (cHCO3−) are observed, it can lead to confusion among clinicians and potential for misdiagnosis. Here we assessed the agreement between cHCO3− from the Radiometer blood gas analyzer and mHCO3− from 3 different chemistry instruments. Methods: Three institutions that measure bicarbonate using chemistry analyzers from 3 different manufacturers and derive bicarbonate on Radiometer blood gas analyzers participated in this study. De-identified patient data include plasma mHCO3− and blood gas cHCO3− results (arterial and venous) collected within +/− 20 min. Correlations and biases were determined. Results: Deming regression analysis showed good correlations between cHCO3− and mHCO3−. Bland–Altman analysis revealed the greatest bias between Radiometer and Abbott Architect (−2.63 mmol/L), followed by Siemens Advia (0.49 mmol/L) and Beckman AU680 (−0.45 mmol/L). Conclusions: This is the first study to compare cHCO3− from the Radiometer blood gas analyzer against mHCO3− results from multiple chemistry analyzers. Our results suggest that the Radiometer blood gas analyzer, Siemens Advia, and Beckman AU680 agree well with each other. However, bicarbonate results may be negatively biased when measured on the Abbott Architect compared with the other methods.